Winton Capital »

Taro Pharmaceutical Industries shares owned by Winton Capital

Quarter-by-quarter ownership of Taro Pharmaceutical Industries (TARO) shares owned by Winton Capital from 13F filings

Historical chart of Winton Capital investment in Taro Pharmaceutical Industries

Tip: Access up to 7 years of quarterly data

All positions including Taro Pharmaceutical Industries held by Winton Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taro Pharmaceutical Industries by Winton Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $307k 7.3k 41.78
2023-09-30 $269k 7.1k 37.71

More positions owned by Winton Capital

Berkshire Hathaway Inc Del Cl A (BRK.A)
Select Sector Spdr Tr Communication (XLC)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Select Sector Spdr Tr Financial (XLF)
Select Sector Spdr Tr Technology (XLK)
Select Sector Spdr Tr Rl Est Sel Sec (XLRE)
Union Pacific Corporation (UNP)
Centene Corporation (CNC)
Copart (CPRT)
Sempra Energy (SRE)
Expedia Group Com New (EXPE)
NetApp (NTAP)
Jabil Circuit (JBL)
Constellation Energy (CEG)
Metropcs Communications (TMUS)

View all positions for Winton Capital

Top funds holding Taro Pharmaceutical Industries

Krensavage Asset Management
Dimensional Fund Advisors
Brandes Investment Partners
Vanguard Group
ARK Investment Management
Norges Bank Investment Management
Arrowstreet Capital, Limited Partnership
UBS Group
Bank of New York Mellon
Charles Schwab Investment Management
Swiss National Bank
Citadel Advisors
Barclays
Connor, Clark & Lunn Investment Management
Inspire Advisors

View all funds holding Taro Pharmaceutical Industries